Sumitomo starts clinical trial on iPS cell-derived dopamine neural progenitor cells in the USA
https://bio.nikkeibp.co.jp/atcl/news/p1/23/12/26/11462/ Sumitomo Pharma announced that the Stanford Stem Cell Institute
https://bio.nikkeibp.co.jp/atcl/news/p1/23/12/26/11462/ Sumitomo Pharma announced that the Stanford Stem Cell Institute
https://bio.nikkeibp.co.jp/atcl/news/p1/23/12/21/11450/ Sysmex has acquired additional shares of Megakaryon, a company
https://bio.nikkeibp.co.jp/atcl/news/p1/23/12/18/11422/ Euglena announced that it will start to utilize Euglena
https://bio.nikkeibp.co.jp/atcl/news/p1/23/12/13/11409/ On December 13, 2023, Kao announced that it will
Bildschirmfoto 2023-12-14 um 13.48.28.png
https://www.nedo.go.jp/news/press/AA5_101710. As part of the NEDO-subsidized “Strategic Energy Saving Technology
https://www.nedo.go.jp/news/press/AA5_101705.html The CO2 transport test ship “Ekusukuru”, which incorporates a
A recent article in the magazine Nikkei Biotech looks at